Customized solutions for Intimate Issues | VagiBiom® Restore

VagiBIOM®(Vaginal Microbiome)Restore

VagiBIOM® (Vaginal Microbiome)

Custom solutions for your Intimate Issues

Custom solutions for your Intimate Issues

Customized solutions for Intimate Issues | VagiBiom® Restore

VagiBIOM® (Vaginal Microbiome)Restore

VagiBIOM®(Vaginal Microbiome)Restore

Custom solutions for your Intimate Issues

Custom solutions for your Intimate Issues

The vagina houses a complex microbial ecosystem that, in most women, is dominated by bacteria of the genus Lactobacillus. These microbes convert sugars shed from the vaginal wall into lactic acid, which provides an important first line of defense against pathogens. The vaginal microbiome varies depending on diet, stress level, long-term antibiotic use, menstrual cycle, and sexual activity. Vaginal microbiome dysbiosis leads to bacterial vaginosis that can be devastating. The condition, caused by excessive bacterial growth in the vagina, often results in burning feelings, discharge, and a foul odor. 

Although not life-threatening, it can cause infertility, premature births, and increased susceptibility to sexually transmitted illnesses. As a result, it can lead to long-term disruptions in sexual relationships and quality of life. The current conventional treatment—a course of antibiotics—is not effective in all women. An imbalanced flora can also be a risk factor for higher chances of ovarian cancer.

Customized solutions for Intimate Issues | VagiBiom® Restore

Although not life-threatening, it can cause infertility, premature births, and increased susceptibility to sexually transmitted illnesses. As a result, it can lead to long-term disruptions in sexual relationships and quality of life. The current conventional treatment—a course of antibiotics—is not effective in all women. An imbalanced flora can also be a risk factor for higher chances of ovarian cancer.

Vaginal microbiome reengineering using vaginal probiotics, prebiotics, and vaginal tissue fluid is a promising new way of modulating beneficial flora against BV and other infections. We at Biom Pharmaceuticals are at the leading edge in vaginal microbiome research.

VagiBIOM®(Vaginal Microbiome)Restore

Each woman’s vaginal flora and microbiome changes are unique; we believe no size fits all models for significant quality of life vaginal issues. We make specific vaginal beneficial flora systems based on customer’s ongoing problems and feedback on various parameters.

VagiBIOM® (Vaginal Microbiome)Restore

Each woman’s vaginal flora and microbiome changes are unique; we believe no size fits all models for significant quality of life vaginal issues. We make specific vaginal beneficial flora systems based on customer’s ongoing problems and feedback on various parameters.

What is VagiBIOM® (Vaginal Microbiome)Restore?

Our VagiBIOM®(Vaginal Microbiome)Restore plan is our customized solution for women’s intimate vaginal issues. Our first step is to assesses customer’s vaginal health status and previous issues. We then formulate natural formulation using specific probiotics with high tissue adherence and vaginal tissue fluid in a slow-release matrix to restore and replenish a healthy vaginal microbiome.

How does it work?

Interested customers fill in a questionnaire to assess vaginal microbiome status, and our technical and formulation specialists assesses and recommend a specific formulation that might naturally balance the vaginal microbiome. You can discuss this with your healthcare provider and then decide whether you want us to make a custom microbiome formulation. We will follow up to see how the formulation is working for your specific flora issues.

References

Lev-Sagie A et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med. 2019 Oct;25(10):1500-1504
DeLong K et al. Vaginal Microbiota Transplantation: The Next Frontier. J Law Med Ethics. 2019 Dec;47(4):555-567
Ma D, Chen Y, Chen T. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis. FEMS Microbiol Lett. 2019 Feb 1;366(4):fnz025